Granulocyte-Macrophage Colony-Stimulating Factor
- Name
- Granulocyte-Macrophage Colony-Stimulating Factor
- Accession Number
- DBCAT004142
- Description
Not Available
- Drugs
Drug Drug Description Regramostim Investigated for use/treatment in adverse effects (chemotherapy) and bone marrow transplant. Molgramostim Molgramostim has been used in trials studying the treatment of Bronchiectasis, Cystic Fibrosis, Pulmonary Alveolar Proteinosis, Acute Respiratory Distress Syndrome, and Autoimmune Pulmonary Alveolar Proteinosis. Sargramostim A modified form of recombinant human granulocyte-macrophage colony stimulating factor used to increase immune cell production after myelosuppressive therapy or bone marrow transplant. - Drugs & Drug Targets